Jaguar Health, Inc.
Develops plant-based, non-opioid GI therapies for humans and animals.
JAGX | NDAQ
Overview
Corporate Details
- ISIN(s):
- US47010C6075
- LEI:
- Country:
- United States of America
- Address:
- 200 PINE STREET SUITE 400, 94104 SAN FRANCISCO
- Website:
- https://jaguar.health/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Jaguar Health, Inc. is a commercial-stage pharmaceuticals company focused on discovering, developing, and commercializing novel, plant-based prescription medicines to address urgent global health needs. The company's core focus is on sustainably derived, non-opioid therapies for gastrointestinal (GI) diseases in both humans and animals. Its product portfolio spans multiple stages of development, from preclinical to commercial approval. Key development programs include crofelemer for the preventative treatment of cancer therapy-related diarrhea and for rare disease indications such as short bowel syndrome.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Jaguar Health, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Jaguar Health, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Jaguar Health, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
